MORPHEUS: A phase Ib/II multi-trial platform evaluating the efficacy and safety of cancer immunotherapy (CIT)-based combinations in patients (pts) with gastric or pancreatic cancer Meeting Abstract


Authors: Manji, G. A.; Bendell, J. C.; Oh, D. Y.; Kim, K. P.; Macarulla, T.; Ponz-Sarvisé, M.; Ajani, J. A.; Oberstein, P.; Janjigian, Y. Y.; Chau, I.; Abdullah, H.; He, X.; Zhang, X.; Wang, J.; Barak, H.; Cha, E.; Grossman, W.; Bang, Y. J.
Abstract Title: MORPHEUS: A phase Ib/II multi-trial platform evaluating the efficacy and safety of cancer immunotherapy (CIT)-based combinations in patients (pts) with gastric or pancreatic cancer
Meeting Title: 2018 Gastrointestinal Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 36
Issue: 4 Suppl.
Meeting Dates: 2018 Jan 18-20
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2018-02-01
Language: English
ACCESSION: WOS:000436174100510
PROVIDER: wos
DOI: 10.1200/JCO.2018.36.4_suppl.TPS530
Notes: Meeting Abstract: PS530 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Yelena Yuriy Janjigian
    394 Janjigian
Related MSK Work